1298O_PRAlectinib vs crizotinib in treatment-naïve ALK+...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1298O_PRAlectinib vs crizotinib in treatment-naïve ALK+ NSCLC: CNS efficacy results from the ALEX study

Gadgeel, S., Peters, S., Mok, T.S.K., Shaw, A.T., Kim, D-W., Ou, S-H.I., Perol, M., Dziadziuszko, R., Ahn, J.S., Rosell, R., Zeaiter, A., Mitry, E., Nueesch, E., Balas, B., Camidge, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.057
Date:
September, 2017
File:
PDF, 107 KB
english, 2017
Conversion to is in progress
Conversion to is failed